IPGP 10-Q Quarterly Report March 31, 2018

IPG PHOTONICS CORP

10-Qs and 10-Ks

10-Q	Quarter ended March 31, 2025
10-K	Fiscal year ended Dec. 31, 2024
10-Q	Quarter ended Sept. 30, 2024
10-Q	Quarter ended June 30, 2024
10-Q	Quarter ended March 31, 2024
10-K	Fiscal year ended Dec. 31, 2023
10-Q	Quarter ended Sept. 30, 2023
10-Q	Quarter ended June 30, 2023
10-Q	Quarter ended March 31, 2023
10-K	Fiscal year ended Dec. 31, 2022
10-Q	Quarter ended Sept. 30, 2022
10-Q	Quarter ended June 30, 2022
10-Q	Quarter ended March 31, 2022
10-K	Fiscal year ended Dec. 31, 2021
10-Q	Quarter ended Sept. 30, 2021
10-Q	Quarter ended June 30, 2021
10-Q	Quarter ended March 31, 2021
10-K	Fiscal year ended Dec. 31, 2020
10-Q	Quarter ended Sept. 30, 2020
10-Q	Quarter ended June 30, 2020
10-Q	Quarter ended March 31, 2020
10-K	Fiscal year ended Dec. 31, 2019
10-Q	Quarter ended Sept. 30, 2019
10-Q	Quarter ended June 30, 2019
10-Q	Quarter ended March 31, 2019
10-K	Fiscal year ended Dec. 31, 2018
10-Q	Quarter ended Sept. 30, 2018
10-Q	Quarter ended June 30, 2018
10-Q	Quarter ended March 31, 2018
10-K	Fiscal year ended Dec. 31, 2017
10-Q	Quarter ended Sept. 30, 2017
10-Q	Quarter ended June 30, 2017
10-Q	Quarter ended March 31, 2017
10-K	Fiscal year ended Dec. 31, 2016
10-Q	Quarter ended Sept. 30, 2016
10-Q	Quarter ended June 30, 2016
10-Q	Quarter ended March 31, 2016
10-K	Fiscal year ended Dec. 31, 2015
10-Q	Quarter ended Sept. 30, 2015
10-Q	Quarter ended June 30, 2015
10-Q	Quarter ended March 31, 2015
10-K	Fiscal year ended Dec. 31, 2014
10-Q	Quarter ended Sept. 30, 2014
10-Q	Quarter ended June 30, 2014
10-Q	Quarter ended March 31, 2014
10-K	Fiscal year ended Dec. 31, 2013
10-Q	Quarter ended Sept. 30, 2013
10-Q	Quarter ended June 30, 2013
10-Q	Quarter ended March 31, 2013
10-K	Fiscal year ended Dec. 31, 2012
10-Q	Quarter ended Sept. 30, 2012
10-Q	Quarter ended June 30, 2012
10-Q	Quarter ended March 31, 2012
10-K	Fiscal year ended Dec. 31, 2011
10-Q	Quarter ended Sept. 30, 2011
10-Q	Quarter ended June 30, 2011
10-Q	Quarter ended March 31, 2011
10-K	Fiscal year ended Dec. 31, 2010
10-Q	Quarter ended Sept. 30, 2010
10-Q	Quarter ended June 30, 2010
10-Q	Quarter ended March 31, 2010
10-K	Fiscal year ended Dec. 31, 2009

PROXIES

DEF 14A	Filed on April 7, 2025
DEF 14A	Filed on May 9, 2024
DEF 14A	Filed on April 13, 2023
DEF 14A	Filed on April 6, 2022
DEF 14A	Filed on April 9, 2021
DEF 14A	Filed on April 7, 2020
DEF 14A	Filed on April 5, 2019
DEF 14A	Filed on April 10, 2018
DEF 14A	Filed on April 5, 2017
DEF 14A	Filed on April 5, 2016
DEF 14A	Filed on April 7, 2015
DEF 14A	Filed on April 15, 2014
DEF 14A	Filed on April 15, 2013
DEF 14A	Filed on April 16, 2012
DEF 14A	Filed on April 14, 2011
DEF 14A	Filed on April 15, 2010

10-Q 1 ipgp-20180331x10q.htm 10-Q Document

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________________________

FORM 10-Q

__________________________________________



ý	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2018



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-33155

IPG PHOTONICS CORPORATION

(Exact name of registrant as specified in its charter)



Delaware	04-3444218
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification Number)

50 Old Webster Road, Oxford, Massachusetts	01540
(Address of principal executive offices)	(Zip code)

(508) 373-1100

(Registrant’s telephone number, including area code)

__________________________________________

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ý NO ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES ý NO ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.



Large Accelerated Filer	ý	Accelerated Filer	¨
Non-Accelerated Filer	¨	Smaller Reporting Company	¨
Emerging Growth Company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ¨ NO ý

As of May 2, 2018 , there were 54,223,150 and 53,694,483 shares of the registrant's common stock issued and outstanding, respectively.

TABLE OF CONTENTS



	Page
Part I. Financial Information	1
Item 1. Financial Statements	1
Consolidated Balance Sheets: March 31, 2018 and December 31, 2017	1
Consolidated Statements of Income: Three Months Ended March 31, 2018 and 2017	2
Consolidated Statements of Comprehensive Income: Three Months Ended March 31, 2018 and 2017	3
Consolidated Statements of Cash Flows: Three Months Ended March 31, 2018 and 2017	4
Consolidated Statements of Equity: Three Months Ended March 31, 2018 and 2017	5
Notes to Consolidated Financial Statements	6
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	16
Item 3. Quantitative and Qualitative Disclosures About Market Risk	22
Item 4. Controls and Procedures	24
Part II. Other Information	25
Item 1. Legal Proceedings	25
Item 1A. Risk Factors	25
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	25
Item 3. Defaults Upon Senior Securities	25
Item 4. Mine Safety Disclosures	25
Item 5. Other Information	26
Item 6. Exhibits	26
Signatures	27
EX-31.1 CERTIFICATION OF CEO PURSUANT TO RULE 13a-14(a)
EX-31.2 CERTIFICATION OF CFO PURSUANT TO RULE 13a-14(a)
EX-32 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 1350
EX-101.INS XBRL INSTANCE DOCUMENT
EX-101.SCH XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.LAB XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
EX-101.DEF XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

Table of Contents

PART I-FINANCIAL INFORMATION

ITEM 1. UNAUDITED INTERIM FINANCIAL STATEMENTS

IPG PHOTONICS CORPORATION

CONSOLIDATED BALANCE SHEETS



	March 31,			December 31,
	2018			2017
	(In thousands, except share and per share data)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	969,123		$	909,900
Short-term investments	206,786			206,257
Accounts receivable, net	235,477			237,278
Inventories	356,375			307,712
Prepaid income taxes	42,430			44,944
Prepaid expenses and other current assets	54,695			47,919
Total current assets	1,864,886			1,754,010
DEFERRED INCOME TAXES, NET	24,940			26,976
GOODWILL	55,705			55,831
INTANGIBLE ASSETS, NET	49,284			51,223
PROPERTY, PLANT AND EQUIPMENT, NET	483,907			460,206
OTHER ASSETS	19,285			19,009
TOTAL	$	2,498,007		$	2,367,255
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Current portion of long-term debt	$	3,621		$	3,604
Accounts payable	33,369			35,109
Accrued expenses and other liabilities	135,750			144,417
Income taxes payable	22,820			15,773
Total current liabilities	195,560			198,903
DEFERRED INCOME TAXES AND OTHER LONG-TERM LIABILITIES	112,612			100,652
LONG-TERM DEBT, NET OF CURRENT PORTION	44,466			45,378
Total liabilities	352,638			344,933
COMMITMENTS AND CONTINGENCIES (NOTE 12)
IPG PHOTONICS CORPORATION EQUITY:
Common stock, $0.0001 par value, 175,000,000 shares authorized; 54,204,016 and 53,742,849 shares issued and outstanding, respectively, at March 31, 2018; 54,007,708 and 53,629,439 shares issued and outstanding, respectively, at December 31, 2017	5			5
Treasury stock, at cost (461,167 and 378,269 shares held)	(69,004		)	(48,933		)
Additional paid-in capital	714,255			704,727
Retained earnings	1,550,807			1,443,867
Accumulated other comprehensive loss	(50,694		)	(77,344		)
Total IPG Photonics Corporation equity	2,145,369			2,022,322
TOTAL	$	2,498,007		$	2,367,255

See notes to consolidated financial statements.

Table of Contents

IPG PHOTONICS CORPORATION

CONSOLIDATED STATEMENTS OF INCOME



	Three Months Ended March 31,
	2018			2017
	(in thousands, except per share data)
NET SALES	$	359,864		$	285,846
COST OF SALES	156,502			128,579
GROSS PROFIT	203,362			157,267
OPERATING EXPENSES:
Sales and marketing	13,516			10,827
Research and development	28,546			22,780
General and administrative	25,495			17,726
(Gain) loss on foreign exchange	(5,295		)	4,453
Total operating expenses	62,262			55,786
OPERATING INCOME	141,100			101,481
OTHER INCOME (EXPENSE), Net:
Interest income, net	311			308
Other income (expense), net	443			(529		)
Total other income (expense)	754			(221		)
INCOME BEFORE PROVISION FOR INCOME TAXES	141,854			101,260
PROVISION FOR INCOME TAXES	(35,520		)	(26,328		)
NET INCOME	106,334			74,932
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS	—			(13		)
NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION	$	106,334		$	74,945
NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION PER SHARE:
Basic	$	1.98		$	1.40
Diluted	$	1.93		$	1.38
WEIGHTED AVERAGE SHARES OUTSTANDING:
Basic	53,694			53,368
Diluted	55,182			54,370

See notes to consolidated financial statements.

Table of Contents

IPG PHOTONICS CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME



	Three Months Ended March 31,
	2018		2017
	(In thousands)
Net income	$	106,334	$	74,932
Other comprehensive income, net of tax:
Translation adjustments	26,638		26,699
Unrealized gain (loss) on derivatives	2		(16		)
Effect of adopted accounting standards	10		—
Loss on available-for-sale investments, net of tax reclassified to net income	—		298
Total other comprehensive loss	26,650		26,981
Comprehensive income	132,984		101,913
Comprehensive loss attributable to noncontrolling interest	—		11
Comprehensive income attributable to IPG Photonics Corporation	$	132,984	$	101,902

See notes to consolidated financial statements.

Table of Contents

IPG PHOTONICS CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS



	Three Months Ended March 31,
	2018			2017
	(In thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	106,334		$	74,932
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	19,223			14,504
Deferred income taxes	7,401			4,208
Stock-based compensation	6,415			5,351
Unrealized (gains) losses on foreign currency transactions	(1,991		)	3,462
Other	4			842
Provisions for inventory, warranty & bad debt	9,318			9,002
Changes in assets and liabilities that (used) provided cash:
Accounts receivable	7,942			(22,801		)
Inventories	(49,744		)	(22,408		)
Prepaid expenses and other current assets	(2,138		)	(3,972		)
Accounts payable	1,134			(1,560		)
Accrued expenses and other liabilities	(9,509		)	(659		)
Income and other taxes payable	5,264			(10,081		)
Net cash provided by operating activities	99,653			50,820
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of and deposits on property, plant and equipment	(39,113		)	(21,875		)
Proceeds from sales of property, plant and equipment	210			99
Purchases of short-term investments	(70,777		)	(28,173		)
Proceeds from sales of short-term investments	70,161			70,370
Other	76			(47		)
Net cash (used in) provided by investing activities	(39,443		)	20,374
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from line-of-credit facilities	255			1,934
Payments on line-of-credit facilities	(255		)	(1,934		)
Principal payments on long-term borrowings	(895		)	(797		)
Proceeds from issuance of common stock under employee stock option and purchase plans less payments for taxes related to net share settlement of equity awards	3,113			9,600
Purchase of treasury stock, at cost	(20,071		)	(12,539		)
Net cash used in financing activities	(17,853		)	(3,736		)
EFFECT OF CHANGES IN EXCHANGE RATES ON CASH AND CASH EQUIVALENTS	16,866			6,465
NET INCREASE IN CASH AND CASH EQUIVALENTS	59,223			73,923
CASH AND CASH EQUIVALENTS — Beginning of period	909,900			623,855
CASH AND CASH EQUIVALENTS — End of period	$	969,123		$	697,778
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest	$	799		$	447
Cash paid for income taxes	$	19,546		$	31,371
Non-cash transactions:
Demonstration units transferred from inventory to other assets	$	446		$	802
Inventory transferred to machinery and equipment	$	1,618		$	1,051
Changes in accounts payable related to property, plant and equipment	$	(3,296	)	$	(1,310	)

See notes to consolidated financial statements.

Table of Contents

IPG PHOTONICS CORPORATION

CONSOLIDATED STATEMENTS OF EQUITY



	Three Months Ended March 31,
	2018					2017
	(In thousands, except share and per share data)
	Shares		Amount			Shares		Amount
COMMON STOCK
Balance, beginning of year	53,629,439		$	5		53,251,805		$	5
Exercise of stock options and conversion of restricted stock units	196,308		—			281,840		—
Purchased common stock	(82,898	)	—			(107,700	)	—
Balance, end of period	53,742,849		5			53,425,945		5
TREASURY STOCK
Balance, beginning of year	(378,269	)	(48,933		)	(102,774	)	(8,946		)
Purchased treasury stock	(82,898	)	(20,071		)	(107,700	)	(12,539		)
Balance, end of period	(461,167	)	(69,004		)	(210,474	)	(21,485		)
ADDITIONAL PAID-IN CAPITAL
Balance, beginning of year			704,727					650,974
Stock-based compensation			6,415					5,351
Common stock issued under employee stock option plan, net of shares withheld for employee taxes			3,113					9,600
Effect of adopted accounting standards			—					2,078
Balance, end of period			714,255					668,003
RETAINED EARNINGS
Balance, beginning of year			1,443,867					1,094,108
Net income attributable to IPG Photonics Corporation			106,334					74,945
Effect of adopted accounting standards			606					2,145
Balance, end of period			1,550,807					1,171,198
ACCUMULATED OTHER COMPREHENSIVE LOSS
Balance, beginning of year			(77,344		)			(178,583		)
Translation adjustments			26,638					26,675
Unrealized gain (loss) on derivatives, net of tax			2					(16		)
Unrealized loss on available-for-sale investments, net of tax			—					(240		)
Realized loss on available-for-sale investments, net of tax, reclassified to net income			—					538
Effect of adopted accounting standards			10					—
Balance, end of period			(50,694		)			(151,626		)
TOTAL IPG PHOTONICS CORPORATION EQUITY			$	2,145,369				$	1,666,095
NONCONTROLLING INTERESTS ("NCI")
Balance, beginning of year			—					166
Net loss attributable to NCI			—					(13		)
Other comprehensive income attributable to NCI			—					24
Balance, end of period			—					177
TOTAL EQUITY			$	2,145,369				$	1,666,272

See notes to consolidated financial statements.

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation — The accompanying unaudited consolidated financial statements have been prepared by IPG Photonics Corporation, or "IPG", "its" or the "Company". Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). The consolidated financial statements include the Company's accounts and those of its subsidiaries. All intercompany balances have been eliminated in consolidation. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in the Company's Annual Report on Form 10-K for the year ended December 31, 2017 .

In the opinion of the Company's management, the unaudited financial information for the interim periods presented reflects all adjustments necessary for a fair presentation of the Company's financial position, results of operations and cash flows. The results reported in these consolidated financial statements are not necessarily indicative of results that may be expected for the entire year.

The Company has evaluated subsequent events through the time of filing this Quarterly Report on Form 10-Q with the SEC.

In accordance with Accounting Standards Codification ("ASC") 606, "Revenue from Contracts with Customers," ("ASC 606" or the "new revenue standard"), the following significant accounting policies have been adopted as of January 1, 2018.

Revenue Recognition — Revenue is recognized when transfer of control to the customer occurs in an amount reflecting the consideration that the Company expects to be entitled. In order to achieve this core principle, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with a customer. As part of its consideration of the contract, the Company evaluates certain factors including the customer's ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct as the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled. As the Company's standard payment terms are less than one year, the Company has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company's performance obligation is satisfied), which typically occurs at shipment.

The Company often receives orders with multiple delivery dates that may extend across several reporting periods. The Company allocates the transaction price of the contract to each delivery based on the product standalone selling price. The Company invoices for each scheduled delivery upon shipment and recognizes revenues for such delivery at that point, assuming transfer of control has occurred. As scheduled delivery dates are generally within one year, under the optional exemption provided by ASC 606-10-50-14 revenues allocated to future shipments of partially completed contracts are not disclosed.

Rights of return generally are not included in customer contracts. Accordingly, upon application of steps one through five above, product revenue is recognized upon shipment and transfer of control. Returns are infrequent and are recorded as a reduction of revenue.

In certain subsidiaries the Company provides sales commissions to sales representatives based on sales volume. The Company has determined that the incentive portions of its sales commissions qualify as contract costs. The Company has elected the practical expedient in ASC 340-40-25-4 to expense sales commissions when incurred as the amortization period of the asset that would otherwise have been recognized is one year or less.

Revenue Recognition at a Point in Time — Revenues recognized at a point in time consist primarily of product, installation, and service sales. The Company sells products to original equipment manufacturers ("OEMs"), that supply materials processing laser systems, communications systems, medical laser systems and other laser systems for advanced applications to end users. The Company also sells products to end users that use IPG products directly to build their own systems, which incorporate IPG products or use IPG products as an energy or light source. The Company recognizes revenue

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(In thousands, except share and per share data)

for laser and spare part sales following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. Installation revenue is recognized upon completion of the installation service, which typically occurs within 90 days of delivery. For laser systems that carry customer specific processing requirements, revenue is recognized at the latter of customer acceptance date or shipment date if the customer acceptance is made prior to shipment. When sales contracts contain multiple performance obligations, such as the shipment or delivery of products and installation, the Company allocates the transaction price to each performance obligation identified in the contract based on relative standalone selling prices and recognizes the related revenue as control of each individual product or service is transferred to the customer, in satisfaction of the corresponding performance obligations.

Revenue Recognition over Time — The Company offers extended warranty agreements, which extend the standard warranty periods. Warranties are limited and provide that the product meets specifications and is free from defects in materials and workmanship. Extended warranties are sold separately from products and represent a distinct performance obligation. Revenue related to the performance obligation for extended warranties is recognized over time as the customer simultaneously receives and consumes the benefits provided by the Company. The customer receives the assurance that the product will operate in accordance with agreed-upon specifications evenly during the extended warranty period regardless of whether they make a claim during that period, and therefore, revenue at time of sale is deferred and recognized over the time period of the extended warranty period.

Customer Deposits and Deferred Revenue — When the Company receives consideration from a customer or such consideration is unconditionally due prior to transferring goods or services under the terms of a sales contract, the Company records customer deposits or deferred revenue, which represent contract liabilities. The Company recognizes deferred revenue as net sales after control of the goods or services has been transferred to the customer and all revenue recognition criteria are met.

2. RECENT ACCOUNTING PRONOUNCEMENTS

Adopted Pronouncements —

On January 1, 2018, the Company adopted ASC 606 and all related amendments using the modified retrospective method for contracts that were not completed as of the date of initial application. The Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The Company expects the impact of the adoption of the new standard to be immaterial to net income on an ongoing basis.

A majority of revenue continues to be recognized at a point in time when control transfers based on the terms of underlying contact. Under the new revenue standard, the Company will change from deferring revenue for installation services in an amount equal to the greater of the cash received related to installation or the fair value to deferring the standalone selling price for these services.

In February 2018, the FASB issued ASU No. 2018-02, "Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income" ("ASU 2018-02"). ASU 2018-02 allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act ("the Act"). The Company adopted this standard during the first quarter of 2018, which resulted in the reclassification of $10 related to the tax effect of unrealized gains on derivatives.

In October 2016, the FASB issued ASU No. 2016-16, "Income Taxes (Topic 740) - Intra-Entity Transfers of Assets other than Inventory" ("ASU 2016-16"). ASU 2016-16 eliminates the current exception that prohibits the recognition of current and deferred income tax consequences for intra-entity asset transfers (other than inventory) until the asset has been sold to an outside party. The amendments have been applied on a modified retrospective basis through a cumulative effect adjustment to retained earnings. The Company adopted this standard during the first quarter of 2018, which resulted in the reclassification of prepaid income taxes, deferred income taxes and retained earnings.

The cumulative effect of the changes made to the Company's consolidated January 1, 2018 balance sheet for the adoption of ASC 606, ASU 2018-02 and ASU 2016-16 was as follows:

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(In thousands, except share and per share data)



	Balance at			Adoption of			Adoption of			Adoption of			Balance at
	12/31/2017			ASC 606			ASU 2018-02			ASU 2016-16			1/1/2018
Balance Sheet
Prepaid income taxes	$	44,944		$	—		$	—		$	(1,203	)	$	43,741
Deferred income tax assets	26,976			(55		)	—			1,229			28,150
Customer deposits and deferred revenue (short-term)	47,324			(816		)	—			—			46,508
Income taxes payable	15,773			37			—			—			15,810
Deferred income tax liabilities	21,362			134			—			—			21,496
Retained earnings	1,443,867			590			(10		)	26			1,444,473
Accumulated other comprehensive loss	(77,344		)	—			10			—			(77,334		)

In January 2017, the FASB issued ASU No. 2017-04, "Intangibles—Goodwill and Other (Topic 350)" ("ASU 2017-04"). ASU 2017-04 simplifies the accounting for goodwill impairments by eliminating step 2 from the goodwill impairment test. The amendments are applied prospectively upon adoption. The Company early adopted this standard during the first quarter of 2018. The Company performs its annual goodwill impairment assessment on October 1st. The new impairment test will be used in the annual assessment or if events or changes in circumstances indicate that the carrying amount may not be recoverable and an impairment analysis is performed.

Other Pronouncements Currently Under Evaluation —

In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)" ("ASU 2016-02"). ASU 2016-02 requires a lessee to recognize assets and liabilities on the balance sheet for leases with lease terms greater than twelve months. ASU 2016-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, and early adoption is permitted. The Company is continuing to evaluate the standard but does not expect that it will have a material effect on its consolidated financial statements upon adoption.

3. REVENUE FROM CONTRACTS WITH CUSTOMERS

The following tables represent a disaggregation of revenue from contracts with customers for the three months ended March 31, 2018 :



Sales by Application
Materials processing	$	339,214
Other applications	20,650
Total	$	359,864



Sales by Product
High Power Continuous Wave ("CW") Lasers	$	230,574
Medium Power CW Lasers	21,470
Low Power CW Lasers	3,929
Pulsed Lasers	38,253
Quasi-Continuous Wave ("QCW") Lasers	16,200
Other Revenue including Amplifiers, Laser Systems, Service, Parts, Accessories and Change in Deferred Revenue	49,438
Total	$	359,864

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(In thousands, except share and per share data)



Sales by Geography
United States and other North America	$	39,177
Europe:
Germany	33,236
Other including Eastern Europe/CIS	82,978
Asia and Australia:
China	149,973
Japan	19,629
Other	34,207
Rest of World	664
Total	$	359,864



Timing of Revenue Recognition
Goods and services transferred at a point in time	$	358,852
Services transferred over time	1,012
Total	$	359,864

Before the transition date (under ASC 605, Revenue Recognition ), the Company deferred revenue for installation services in an amount equal to the greater of the cash received or the fair value for installation. Under the new revenue standard, the standalone selling price for installation services is deferred until control has transferred. The standalone selling price for installation services is determined based on the estimated number of days of service technician time required for installation at standard service rates. The impact of applying ASC 606 was an increase in revenue recognized during the three months ended March 31, 2018 of $801 as compared to revenue accounted for under ASC 605.

The Company enters into contracts to sell lasers and spare parts, for which revenue is generally recognized upon shipment or delivery, depending on the terms of the contract. The Company also provides installation services and extended warranties. The Company frequently receives consideration from a customer prior to transferring goods to the customer under the terms of a sales contract. The Company records customer deposits related to these prepayments, which represent a contract liability. The Company also records deferred revenue related to installation services when consideration is received before the services have been performed. The Company recognizes customer deposits and deferred revenue as net sales after control of the goods or services has been transferred to the customer and all revenue recognition criteria is met. The Company bills customers for extended warranties upon entering into the agreement with the customer, resulting in deferred revenue. Revenue is recognized ratably over the term of the extended warranty agreement as the customer receives and consumes the benefits of such services.

The following table reflects the changes in the Company's contract liabilities for the three months ended March 31, 2018 :



	March 31,	January 1,
	2018	2018	Change
Contract liabilities
Customer deposits	43,234	36,937	6,297		17.0	%
Deferred revenue - current	7,107	9,571	(3,280	)	(31.6	)%
Deferred revenue - long-term	1,472	182	1,290		708.8	%

Customer deposits increased from January 1, 2018 to March 31, 2018 based on seasonality in the Asian market. During the three months ended March 31, 2018 , the Company recognized revenue of $28,332 that was included in the customer deposits and deferred revenue balances at the beginning of the period.

The following table represents the Company's remaining performance obligations for sales of installation services and extended warranties and contracts with customer acceptance provisions included in deferred revenue as of March 31, 2018 :

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(In thousands, except share and per share data)



	Remaining Performance Obligations
	2018		2019		2020		2021		2022		2023		Total
Revenue expected to be recognized upon customer acceptance	$	4,146	$	—	$	—	$	—	$	—	$	—	$	4,146
Revenue expected to be recognized on contracts for installation services	551		—		—		—		—		—		551
Revenue expected to be recognized for extended warranty agreements	2,292		894		409		218		62		6		3,882
Total	$	6,989	$	894	$	409	$	218	$	62	$	6	$	8,579

4. FAIR VALUE MEASUREMENTS

The Company's financial instruments consist of cash equivalents, short-term investments, accounts receivable, auction rate securities, accounts payable, drawings on revolving lines of credit, long-term debt, contingent purchase consideration and interest rate swap.

The valuation techniques used to measure fair value are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect internal market assumptions. These two types of inputs create the following fair value hierarchy: Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.

The carrying amounts of cash equivalents, short-term investments, accounts receivable, accounts payable and drawings on revolving lines of credit are considered reasonable estimates of their fair market value due to the short maturity of most of these instruments or as a result of the competitive market interest rates, which have been negotiated. At March 31, 2018 and December 31, 2017 , the Company's long-term notes consisted of a variable rate long-term note and a fixed rate long-term note. The book value of the long-term notes approximates the fair market value.

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(In thousands, except share and per share data)

The following table presents information about the Company's assets and liabilities measured at fair value:



			Fair Value Measurements at March 31, 2018
	Total		Level 1		Level 2		Level 3
Assets
Cash equivalents	$	462,087	$	462,087	$	—	$	—
Short-term investments	206,402		206,402		—		—
Interest rate swap	18		—		18		—
Auction rate securities	1,019		—		—		1,019
Total assets	$	669,526	$	668,489	$	18	$	1,019
Liabilities
Long-term notes	$	48,087	$	—	$	48,087	$	—
Contingent purchase consideration	902		—		—		902
Total liabilities	$	48,989	$	—	$	48,087	$	902

			Fair Value Measurements at December 31, 2017
			Fair Value Measurements at December 31, 2017
	Total		Level 1		Level 2		Level 3
Assets
Cash equivalents	$	425,917	$	425,917	$	—	$	—
Short-term investments	206,161		206,161		—		—
Interest rate swap	16		—		16		—
Auction rate securities	1,016		—		—		1,016
Total assets	$	633,110	$	632,078	$	16	$	1,016
Liabilities
Long-term notes	$	48,982	$	—	$	48,982	$	—
Contingent purchase consideration	902		—		—		902
Total liabilities	$	49,884	$	—	$	48,982	$	902

Short-term investments consist of liquid investments including U.S. government and government agency notes, corporate notes, commercial paper and certificates of deposit with original maturities of greater than three months but less than one year and are recorded at amortized cost. The fair value of the short-term investments considered held-to-maturity as of March 31, 2018 and December 31, 2017 was $206,402 and $206,161 , respectively, which represents an unrealized loss of $384 and $96 , respectively, as compared to the book value recorded on the Consolidated Balance Sheets for the same periods.

The fair value of the interest rate swap considered pricing models whose inputs are observable for the securities held by the Company.

The fair value of the auction rate securities was determined using prices observed in inactive markets with limited observable data for the securities held by the Company.

The fair value of contingent purchase consideration was determined using an income approach at the respective business combination date and at the reporting date. That approach is based on significant inputs that are not observable in the market and include key assumptions such as assessing the probability of meeting certain milestones required to earn the contingent purchase consideration.

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(In thousands, except share and per share data)

The following table presents information about the Company's movement in Level 3 assets and liabilities measured at fair value:



	Three Months Ended March 31,
	2018		2017
Auction Rate Securities
Balance, beginning of period	$	1,016	$	1,144
Change in fair value and accretion	3		2
Balance, end of period	$	1,019	$	1,146
Contingent Purchase Consideration
Balance, beginning of period	$	902	$	—
Balance, end of period	$	902	$	—

5. INVENTORIES

Inventories consist of the following:



	March 31,		December 31,
	2018		2017
Components and raw materials	$	181,928	$	145,261
Work-in-process	35,942		43,646
Finished components and devices	138,505		118,805
Total	$	356,375	$	307,712

The Company recorded inventory provisions totaling $3,357 and $3,971 for the three months ended March 31, 2018 and 2017 , respectively. These provisions relate to the recoverability of the value of inventories due to technological changes and excess quantities. These provisions are reported as a reduction to components and raw materials and finished components and devices.

6. GOODWILL AND INTANGIBLES

The following table sets forth the changes in the carrying amount of goodwill for the three months ended March 31, 2018 :



	Amounts
Balance at January 1	$	55,831
Foreign exchange adjustment	(126		)
Balance at March 31	$	55,705

Intangible assets, subject to amortization, consisted of the following:



	March 31, 2018								December 31, 2017
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Weighted- Average Lives	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Weighted- Average Lives

Patents	$	8,036	$	(5,621	)	$	2,415	8 Years	$	8,036	$	(5,486	)	$	2,550	8 Years
Customer relationships	26,835		(6,246		)	20,589		11 Years	26,768		(5,584		)	21,184		11 Years
Production know-how	6,867		(5,274		)	1,593		8 Years	6,820		(5,035		)	1,785		8 Years
Technology, trademark and tradename	32,628		(7,941		)	24,687		8 Years	32,564		(6,860		)	25,704		8 Years
	$	74,366	$	(25,082	)	$	49,284		$	74,188	$	(22,965	)	$	51,223

Amortization expense for the three months ended March 31, 2018 and 2017 was $1,931 and $1,065 , respectively. The estimated future amortization expense for intangibles for the remainder of 2018 and subsequent years is as follows:

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(In thousands, except share and per share data)



2018	2019	2020	2021	2022	Thereafter	Total
$5,514	$7,325	$6,691	$6,515	$5,667	$17,572	$49,284

7. ACCRUED EXPENSES AND OTHER LIABILITIES

Accrued expenses and other liabilities consist of the following:



	March 31,		December 31,
	2018		2017
Accrued compensation	$	53,496	$	63,203
Customer deposits and deferred revenue	50,341		47,324
Current portion of accrued warranty	22,398		25,059
Other	9,515		8,831
Total	$	135,750	$	144,417

8. PRODUCT WARRANTIES

The Company typically provides one to three -year parts and service warranties on lasers and amplifiers. Most of the Company's sales offices provide support to customers in their respective geographic areas. Warranty reserves have generally been sufficient to cover product warranty repair and replacement costs.

The following table summarizes product warranty accrual activity recorded during the three months ended March 31, 2018 and 2017 .



	2018			2017
Balance at January 1	$	47,517		$	33,978
Provision for warranty accrual	5,574			4,523
Warranty claims	(3,808		)	(2,966		)
Foreign currency translation	708			438
Balance at March 31	$	49,991		$	35,973

Accrued warranty reported in the accompanying consolidated financial statements as of March 31, 2018 and December 31, 2017 consisted of $22,398 and $25,059 in accrued expenses and other liabilities and $27,593 and $22,458 in other long-term liabilities, respectively.

9. FINANCING ARRANGEMENTS

The Company's borrowings under existing financing arrangements consist of the following:



	March 31,			December 31,
	2018			2017
Long-term notes	$	48,087		$	48,982
Less: current portion	(3,621		)	(3,604		)
Total long-term debt	$	44,466		$	45,378

At March 31, 2018 , the Company has an unsecured long-term note of $21,672 of which $1,188 is the current portion. The interest on this unsecured long-term note is variable at 1.20% above LIBOR and is fixed using an interest rate swap at 2.85% per annum. The unsecured long-term note matures in May 2023, at which time the outstanding principal balance will be $15,438 . Also at March 31, 2018 , the Company has another long-term note that is secured by its corporate aircraft with a outstanding principal balance of $26,415 of which $2,433 is the current portion. The interest on this collateralized long-term note is fixed at 2.74% per annum. The collateralized long-term note matures in July 2022, at which time the outstanding principal balance will be $15,375 .

The Company also maintains U.S. and Euro lines-of-credit which are available to certain foreign subsidiaries and allow for borrowings in the local currencies of those subsidiaries. At March 31, 2018 and December 31, 2017 , there were no amounts drawn on the U.S. line-of-credit, and there were $556 and $520 , respectively, of guarantees issued against the facility which

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(In thousands, except share and per share data)

reduce the amount of the facility available to draw. At March 31, 2018 and December 31, 2017 , there were no amounts drawn on the Euro lines-of-credit, and there were $798 and $798 , respectively, of guarantees issued against those facilities which reduce the amount available to draw. After providing for the guarantees used the total unused credit lines and overdraft facilities are $112,714 at March 31, 2018 .

10. DERIVATIVE FINANCIAL INSTRUMENTS

Derivative instruments – The Company's primary market exposures are to interest rates and foreign exchange rates. The Company from time to time may use certain derivative financial instruments to help manage these exposures. The Company executes these instruments with financial institutions it judges to be credit-worthy. The Company does not hold or issue derivative financial instruments for trading or speculative purposes.

The Company recognizes all derivative financial instruments as either assets or liabilities at fair value in the consolidated balance sheets. The Company's only derivative financial instrument is an interest rate swap that is classified as a cash flow hedge of its variable rate debt.

The fair value amounts in the consolidated balance sheets were:



Notional Amounts ¹				Other Assets
March 31,		December 31,		March 31,		December 31,
2018		2017		2018		2017
$	21,672	$	21,969	$	18	$	16

(1) Notional amounts represent the gross contract/notional amount of the derivatives outstanding.

The derivative gains and losses in the consolidated statements of income related to the Company's interest rate swap contract was as follows:



	Three Months Ended March 31,
	2018		2017
Effective portion recognized in other comprehensive income, pretax:
Interest rate swap	$	2	$	(27	)

11. COMMITMENTS AND CONTINGENCIES

From time to time, the Company may be involved in disputes and legal proceedings in the ordinary course of its business.

These proceedings may include allegations of infringement of intellectual property, commercial disputes and employment

matters. As of March 31, 2018 and through the filing date of these Financial Statements, the Company has no legal proceedings ongoing that management estimates could have a material effect on the Company's Consolidated Financial Statements.

12. INCOME TAXES

A reconciliation of the total amounts of unrecognized tax benefits is as follows:



	2018		2017
Balance at January 1	$	10,370	$	6,403
Additions for tax positions in current period	750		—
Balance at March 31	$	11,120	$	6,403

Substantially all of the liability for uncertain tax benefits related to various federal, state and foreign income tax matters, would benefit the Company's effective tax rate, if recognized.

The Company's accounting for the Tax Act is incomplete in accordance with SAB 118, which provides guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740. As noted at year-end, the Company

Table of Contents

IPG PHOTONICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(In thousands, except share and per share data)

was able to reasonably estimate certain effects and, therefore, recorded provisional adjustments associated with the deemed repatriation transition tax. The Company has not made any additional measurement-period adjustments related to these items during the quarter, however, the Company is continuing to gather additional information to complete its accounting for these items and expects to complete its accounting within the prescribed measurement period. The Company also recognized an incremental tax expense of $4,443 for the Global Intangible Low Taxed Income ("GILTI") provisions which was partially offset by a benefit of $1,154 related to Foreign Derived Intangible Income ("FDII") deduction in the Tax Act that were effective for the first time during 2018.

13. NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION PER SHARE

The following table sets forth the computation of diluted net income attributable to IPG Photonics Corporation per share:



	Three Months Ended March 31,
	2018		2017
Net income attributable to IPG Photonics Corporation	$	106,334	$	74,945
Weighted average shares	53,694		53,368
Dilutive effect of common stock equivalents	1,488		1,002
Diluted weighted average common shares	55,182		54,370
Basic net income attributable to IPG Photonics Corporation per share	$	1.98	$	1.40
Diluted net income attributable to IPG Photonics Corporation per share	$	1.93	$	1.38

For the three months ended March 31, 2018 and 2017 , respectively, the computation of diluted weighted average common shares excludes 101,400 and 73,300 common stock equivalents because the effect of including them would be anti-dilutive. The shares excluded for the three months ended March 31, 2018 and 2017 , respectively, are comprised of 32,600 and 44,400 RSUs, 59,600 and 11,800 non-qualified stock options and 9,200 and 17,100 performance stock units.

On July 28, 2016, the Company announced that its Board of Directors authorized a share repurchase program (the “Program”) to mitigate the dilutive impact of shares issued upon exercise or release under the Company's various employee and director equity compensation and employee stock purchase plans. Under the Program, the Company's management is authorized to repurchase shares of common stock in an amount not to exceed the number of shares issued to employees and directors under its various employee and director equity compensation and employee stock purchase plans from January 1, 2016 through December 31, 2017. The Program limits aggregate share repurchases to no more than $100,000 over a period ending June 30, 2018.

For the three months ended March 31, 2018 , the Company repurchased 82,898 shares of its common stock with an average price of $242.11 per share in the open market. The impact on the reduction of weighted average shares for the three months ended March 31, 2018 and 2017 was 28,172 shares and 31,140 shares, respectively.

Table of Contents

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion in conjunction with our consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward looking statements that are based on management's current expectations, estimates and projections about our business and operations. Our actual results may differ materially from those currently anticipated and expressed in such forward-looking statements. See "Cautionary Statement Regarding Forward-Looking Statements."

Overview

We develop and manufacture a broad line of high-performance fiber lasers, fiber amplifiers and diode lasers that are used in numerous applications, primarily in materials processing. In addition, we offer laser-based systems for certain markets and applications. We sell our products globally to original equipment manufacturers ("OEMs"), system integrators and end users. We market our products internationally primarily through our direct sales force.

We are vertically integrated such that we design and manufacture most of the key components used in our finished products, from semiconductor diodes to optical fiber preforms, finished fiber lasers and amplifiers. We also manufacture certain complementary products used with our lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads and chillers.

Factors and Trends That Affect Our Operations and Financial Results

In reading our financial statements, you should be aware of the following factors and trends that our management believes are important in understanding our financial performance.

Net sales. We derive net sales primarily from the sale of fiber lasers and amplifiers. We also sell diode lasers, communications systems, laser systems and complementary products. We sell our products through our direct sales organization and our network of distributors and sales representatives, as well as system integrators. We sell our products to OEMs that supply materials processing laser systems, communications systems, medical laser systems and other laser systems for advanced applications to end users. We also sell our products to end users that build their own systems, which incorporate our products or use our products as an energy or light source. Our scientists and engineers work closely with OEMs, systems integrators and end users to analyze their system requirements and match appropriate fiber laser or amplifier specifications. Our sales cycle varies substantially, ranging from a period of a few weeks to as long as one year or more, but is typically several months.

We consider customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with a customer. The majority of our revenue is recognized at a point in time following the transfer of control of products or services to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts.

We develop our products to standard specifications and use a common set of components within our product architectures. Our major products are based upon a common technology platform. We continually enhance these and other products by improving their components and developing new components and new product designs.

The average selling prices of our products generally decrease as the products mature. These decreases result from factors such as decreased manufacturing costs and increases in unit volumes, increased competition, the introduction of new products and market share considerations. In the past, we have lowered our selling prices in order to penetrate new markets and applications. Furthermore, we may negotiate discounted selling prices from time to time with certain customers that purchase multiple units.

Gross margin . Our total gross margin can be significantly affected by total net sales in any period, by product mix, that is, the percentage of our revenue in the period that is attributable to higher or lower power products and the mix of sales between laser and amplifier sources and complete systems, by sales mix between OEM customers who purchase devices from us in high unit volumes and other customers, by mix of sales in different geographies and by other factors, some of which are not under our control.

Within each of our product categories, lasers with a higher average power generally have a higher gross margin; higher power lasers use a greater number of optical components, improving absorption of fixed overhead costs and enabling economies of scale in manufacturing. In addition, certain specialty products have a gross margin which is above our corporate average while the profit margins on some systems can be lower than margins for our laser and amplifier sources, depending on the configuration, volume and competitive forces, among other factors.

Table of Contents

The mix of sales between OEM customers and other customers can affect gross margin because we provide sales price discounts on products based on the number of units ordered. As the number of OEM customers increase and the number of units ordered increases, the average sales price per unit will be reduced. We expect that the impact of reduced sales price per unit will be offset by the manufacturing efficiency provided by high unit volume orders, but the timing and extent of achieving these efficiencies may not always match the mix of sales in any given time period or be realized at all.

We also regularly review our inventory for items that are slow-moving, have been rendered obsolete or determined to be excess. Any provision for such slow-moving, obsolete or excess inventory affects our gross margins. For example, we recorded provisions for slow-moving, obsolete or excess inventory totaling $3.4 million and $4.0 million for the three months ended March 31, 2018 and 2017 , respectively, and $16.9 million, $22.8 million and $15.4 million for the years ended December 31, 2017 , 2016 and 2015 , respectively.

Sales and marketing expense. We expect to continue to expand our worldwide direct sales organization, build and expand applications centers, hire additional sales and marketing personnel at our existing and new geographic locations as well as to support sales of new product lines, increase the number of units for demonstration purposes and otherwise increase expenditures on sales and marketing activities in order to support the growth in our net sales. As such, we expect that our sales and marketing expenses will increase in the aggregate.

Research and development expense. We plan to continue to invest in research and development to improve our existing components and products and develop new components, products, systems and applications technology. The amount of research and development expense we incur may vary from period to period. In general, if net sales continue to increase we expect research and development expense to increase in the aggregate.

General and administrative expense. We expect our general and administrative expenses to increase as we continue to invest in systems and resources in management, finance, legal, information technology, human resources and administration to support our worldwide operations. Legal expenses vary from quarter to quarter based primarily upon the level of litigation and transaction activities.

Foreign Exchange. Because we are a U.S. based company doing business globally, we have both translational and transactional exposure to fluctuations in foreign currency exchange rates. Changes in the relative exchange rate between the U.S. dollar and the foreign currencies in which our subsidiaries operate directly affects our sales, costs and earnings. Differences in the relative exchange rates between where we sell our products and where we incur manufacturing and other operating costs (primarily in the U.S., Germany and Russia) also affects our costs and earnings. Certain currencies experiencing significant exchange rate fluctuations like the Euro, the Russian Ruble, the Japanese Yen and Chinese Yuan have had and could have an additional significant impact on our sales, costs and earnings. Our ability to adjust the foreign currency selling prices of products in response to changes in exchange rates is limited and may not offset the impact of the changes in exchange rates on the translated value of sales or costs. In addition, if we increase the selling price of our products in local currencies, this could have a negative impact on the demand for our products.

Major customers. While we have historically depended on a few customers for a large percentage of our annual net sales, the composition of this group can change from year to year. Net sales derived from our five largest customers as a percentage of our net sales was 25% for the three months ended March 31, 2018 and 28%, 22% and 25% for the full years 2017 , 2016 and 2015 , respectively. One of our customers accounted for 11% and 12% of our net sales for the three months ended March 31, 2018 and 2017 . We seek to add new customers and to expand our relationships with existing customers. We anticipate that the composition of our significant customers will continue to change. If any of our significant customers substantially reduced their purchases from us, our results would be adversely affected.

Results of Operations for the three months ended March 31, 2018 compared to the three months ended March 31, 2017

Net sales. Net sales increased by $74.0 million , or 25.9% , to $359.9 million for the three months ended March 31, 2018 from $285.8 million for the three months ended March 31, 2017 .

Table of Contents



	Three Months Ended March 31,
	2018				2017				Change
			% of Total				% of Total
Materials processing	$	339,214	94.3	%	$	264,131	92.4	%	$	75,083		28.4	%
Other applications	20,650		5.7	%	21,715		7.6	%	(1,065		)	(4.9	)%
Total	$	359,864	100.0	%	$	285,846	100.0	%	$	74,018		25.9	%



Sales by Product	Three Months Ended March 31,
	2018				2017				Change
			% of Total				% of Total
High Power Continuous Wave ("CW") Lasers	$	230,574	64.1	%	$	167,944	58.8	%	$	62,630		37.3	%
Medium Power CW Lasers	21,470		6.0	%	19,742		6.9	%	1,728			8.8	%
Low Power CW Lasers	3,929		1.1	%	3,394		1.2	%	535			15.8	%
Pulsed Lasers	38,253		10.6	%	32,456		11.3	%	5,797			17.9	%
Quasi-Continuous Wave ("QCW") Lasers	16,200		4.5	%	21,368		7.5	%	(5,168		)	(24.2	)%
Other Revenue including Amplifiers, Laser Systems, Service, Parts, Accessories and Change in Deferred Revenue	49,438		13.7	%	40,942		14.3	%	8,496			20.8	%
Total	$	359,864	100.0	%	$	285,846	100.0	%	$	74,018		25.9	%

Materials processing

Sales for materials processing applications increased due to higher sales of high power lasers, medium power lasers, pulsed lasers, and laser systems.

•

The increase in high power laser sales related to growth in cutting applications. High power lasers continue to displace CO2 lasers. We believe this transition has also benefited from an accelerated replacement cycle for older CO2 based cutting systems and from displacement of non-laser technologies which have resulted in higher demand for the fiber based cutting systems sold by our OEM customers. Within the cutting applications, we continue to see a migration to lasers with higher output powers which improve processing speeds and enable processing of thicker materials. The shift towards lasers with higher output powers has also benefited sales due to their higher average selling prices.


•	The increase in medium power sales related to laser sintering and ablation applications, partially offset by a decrease in fine cutting applications.


•	Pulsed laser sales increased due to higher demand for marking and engraving, cleaning and stripping, ablation and solar cell manufacturing applications. Within the pulsed laser category, we experienced rapid growth in sales of our newer green and high power pulsed lasers across a diverse set of applications, and these products represent nearly half of our pulsed laser sales.


•	QCW laser sales decreased due to the expected reduction in demand related to the smartphone investment cycle.

•

Materials processing sales also increased as a result of higher laser systems and parts and service sales, which are included in Other Revenue in the Sales by Product chart above. The increase in laser systems sales was driven by welding, cladding, and research and development applications. Our acquisition of Innovative Laser Technologies during the third quarter of 2017 contributed to the increased sales for welding applications.

Other Applications

Sales for other applications decreased due to lower sales of telecom products partially offset by higher sales of advanced applications and medical products. Advanced application sales are typically uneven from quarter to quarter. Sales of telecom products are included in Other Revenue in the Sales by Product chart above.

Cost of sales and gross margin. Cost of sales increased by $27.9 million , or 21.7% , to $156.5 million for the three months ended March 31, 2018 from $128.6 million for the three months ended March 31, 2017 . Our gross margin increased to 56.5% for the three months ended March 31, 2018 from 55.0% for the three months ended March 31, 2017 . Gross margin increased

Table of Contents

due to increased manufacturing efficiency and product mix which included increased sales of high power, medium power and pulsed lasers with higher average powers. These increases in gross margin were partially offset by lower average selling prices.

Sales and marketing expense. Sales and marketing expense increased by $2.7 million , or 24.8% , to $13.5 million for the three months ended March 31, 2018 from $10.8 million for the three months ended March 31, 2017 . This change was primarily a result of increases in personnel and depreciation expense. As a percentage of sales, sales and marketing expense remained relatively constant at 3.8% for the three months ended March 31, 2018 and 2017.

Research and development expense. Research and development expense increased by $5.7 million , or 25.3% , to $28.5 million for the three months ended March 31, 2018 , compared to $22.8 million for the three months ended March 31, 2017 . This change was primarily a result of increases in personnel, contractors, consultants and depreciation expense. Research and development continues to focus on developing new products, enhancing performance of existing components, improving production processes and developing manufacturing of new components such as crystals and refining production processes to improve manufacturing yields and productivity. New products include lasers that operate at different wavelengths such as UV, visible and mid-IR, lasers with ultrafast pulses, laser based systems for material processing, projection, display and medical as well as accessories such as welding and cutting heads. In addition to new products research and development is focused on enhancing the performance of our existing products by improving their electrical efficiency and increasing their average power. As a percentage of sales, research and development expense decreased to 7.9% for the three months ended March 31, 2018 from 8.0% for the three months ended March 31, 2017 .

General and administrative expense. General and administrative expense increased by $7.8 million , or 43.8% , to $25.5 million for the three months ended March 31, 2018 from $17.7 million for the three months ended March 31, 2017 . This change was primarily a result of increases in personnel, stock-based compensation, accounting, legal, fees and subscriptions, information systems and depreciation expense. As a percentage of sales, general and administrative expense increased to 7.1% for the three months ended March 31, 2018 from 6.2% for the three months ended March 31, 2017 .

Effect of exchange rates on net sales, gross profit and operating expenses. We estimate that, if exchange rates relative to the U.S. Dollar had been the same as one year ago, which were on average Euro 0.94 , Russian Ruble 59 , Japanese Yen 114 and Chinese Yuan 6.89 , respectively, we would have expected net sales to be $30.4 million lower, gross profit to be $19.0 million lower and total operating expenses to be $1.9 million lower.

(Gain) loss on foreign exchange. We incurred a foreign exchange gain of $5.3 million for the three months ended March 31, 2018 as compared to a $4.5 million loss for the three months ended March 31, 2017 . The foreign exchange gain for the three months ended March 31, 2018 was primarily attributable appreciation of the Chinese Yuan. The foreign exchange loss for the three months ended March 31, 2017 was primarily attributable to the appreciation of the Euro and Russian Ruble as compared to the U.S. Dollar.

Interest income, net. Interest income, net, remained relatively constant at $0.3 million of income for the three months ended March 31, 2018 and 2017.

Other income (expense), net. Other income (expense), net, increased to $0.4 million of income for the three months ended March 31, 2018 from $0.5 million of expense for the three months ended March 31, 2017 .

Provision for income taxes. Provision for income taxes was $35.5 million for the three months ended March 31, 2018 compared to $26.3 million for the three months ended March 31, 2017 . The effective tax rates were 25.0% and 26.0% for the three months ended March 31, 2018 and 2017 , respectively. For the three months ended March 31, 2018 , the effective tax rate benefited from the lower effective tax rate for income earned in the United States due to enactment of the Tax Cuts and Jobs Act (the "Tax Act") and an increase in excess tax benefits related to equity compensation, which were partially offset by provisions for uncertain tax positions and other matters. We also recognized an incremental tax expense of $4.4 million for the Global Intangible Low Taxed Income ("GILTI") provisions which was partially offset by a benefit of $1.2 million related to Foreign Derived Intangible Income ("FDII") deduction in the Tax Act that were effective for the first time during 2018.

The Tax Act made broad and complex changes to the U.S. tax code including, but not limited to reducing the U.S. federal corporate tax rate from 35% to 21%. Our accounting for the Tax Act is incomplete in accordance with SAB 118, which provides guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740. As noted at year-end, we were able to reasonably estimate certain effects and, therefore, recorded provisional adjustments associated with the deemed repatriation transition tax. We have not made any additional measurement-period adjustments related to these items during the quarter, however, we are continuing to gather additional information to complete our accounting for these items and expect to complete our accounting within the prescribed measurement period.

Table of Contents

Net income attributable to IPG Photonics Corporation. Net income attributable to IPG Photonics Corporation increased by $31.4 million to $106.3 million for the three months ended March 31, 2018 compared to $74.9 million for the three months ended March 31, 2017 . Net income attributable to IPG Photonics Corporation as a percentage of our net sales increased by 3.3 percentage points to 29.5% for the three months ended March 31, 2018 from 26.2% for the three months ended March 31, 2017 due to the factors described above.

Liquidity and Capital Resources

Our principal sources of liquidity as of March 31, 2018 consisted of cash and cash equivalents of $969.1 million, short-term investments of $206.8 million , unused credit lines and overdraft facilities of $112.7 million and other working capital (excluding cash and cash equivalents and short-term investments) of $493.4 million. This compares to cash and cash equivalents of $909.9 million, short-term investments of $206.3 million , unused credit lines and overdraft facilities of $111.0 million and other working capital (excluding cash and cash equivalents and short-term investments) of $439.0 million as of December 31, 2017 . The increase in cash and cash equivalents of $59.2 million relates primarily to cash provided by operating activities in the three months ended March 31, 2018 of $99.7 million. The increase was partially offset by cash used in investing activities of $39.4 million and cash used in financing activities of $17.9 million . In addition, the effect of exchange rates increased cash and cash equivalents by $16.9 million .

Short-term investments consist of liquid investments including U.S. government and government agency notes, corporate

notes, commercial paper and certificates of deposit with original maturities of greater than three months but less than one year.

Our long-term debt consists of two long-term notes with a combined total outstanding balance at March 31, 2018 of $48.1 million of which $3.6 million is the current portion. We have an unsecured long-term note with an outstanding principal balance at March 31, 2018 of $21.7 million of which $1.2 million is the current portion. The interest on this unsecured long-term note is variable at 1.20% above LIBOR and is fixed using an interest rate swap at 2.85% per annum. The unsecured long-term note matures in May 2023, at which time the outstanding principal balance will be $15.4 million . We have another long-term note that is secured by our corporate aircraft with an outstanding principal balance of $26.4 million of which $2.4 million is the current portion. The interest on this collateralized long-term note is fixed at 2.74% per annum. The collateralized long-term note matures in July 2022, at which time the outstanding principal balance will be $15.4 million .

We believe that our existing cash and cash equivalents, short-term investments, our cash flows from operations and our existing lines of credit provide us with the financial flexibility to meet our liquidity and capital needs, as well as to complete certain acquisitions of businesses and technologies. We intend to continue to pursue acquisition opportunities based upon market conditions and the strategic importance and valuation of the target company. We may consider issuing debt or equity to finance acquisitions depending on the timing and size of the acquisition. Our future long-term capital requirements will depend on many factors including our level of sales, the impact of the economic environment on our sales growth, the timing and extent of spending to support development efforts, the expansion of the global sales and marketing activities, government regulation including trade sanctions, the timing and introductions of new products, the need to ensure access to adequate manufacturing capacity and the continuing market acceptance of our products.

The following table details our line-of-credit facilities as of March 31, 2018 :




Description	Total Facility	Interest Rate	Maturity	Security
U.S. Revolving Line of Credit (1)	Up to $50.0 million	LIBOR plus 0.80% to 1.20%, depending on our performance	April 2020	Unsecured
Euro Credit Facility (Germany) (2)	Euro 50.0 million ($61.6 million)	Euribor plus 0.75% or EONIA 1.00%	July 2020	Unsecured, guaranteed by parent company and German subsidiary
Euro Overdraft Facilities (3)	Euro 2.0 million ($2.5 million)	1.0%-6.5%	October 2018	Common pool of assets of Italian subsidiary


(1)	This facility is available to certain foreign subsidiaries in their respective local currencies. At March 31, 2018 , there were no amounts drawn on this line, however, there were $0.6 million of guarantees issued against the line which reduces total availability.

Table of Contents


(2)	This facility is also available to certain foreign subsidiaries in their respective local currencies. At March 31, 2018 , there were no drawings on this facility, however, there were $0.8 million of guarantees issued against the line which reduces total availability.


(3)	At March 31, 2018 , there were no drawings.

Our largest committed credit lines are with Bank of America N.A. and Deutsche Bank AG in the amounts of $50.0 million and $61.6 million (or 50 million Euro as described above), respectively, and neither of them is syndicated.

We are required to meet certain financial covenants associated with our U.S. revolving line of credit and long-term debt facility. These covenants, tested quarterly, include a debt service coverage ratio and a funded debt to earnings before interest, taxes, depreciation and amortization ("EBITDA") ratio. The debt service coverage covenant requires that we maintain a trailing twelve month ratio of cash flow to debt service that is at least 1.5:1. Debt service is defined as required principal and interest payments during the period. Debt service in the calculation is decreased by our cash held in the U.S.A. in excess of $50 million up to a maximum of $250 million. Cash flow is defined as EBITDA less unfunded capital expenditures. The funded debt to EBITDA covenant requires that the sum of all indebtedness for borrowed money on a consolidated basis be less than three times our trailing twelve months EBITDA. We were in compliance with all such financial covenants as of and for the three months ended March 31, 2018 .

The financial covenants in our loan documents may cause us to not take or to delay investments and actions that we might otherwise undertake because of limits on capital expenditures and amounts that we can borrow or lease. In the event that we do not comply with any one of these covenants, we would be in default under the loan agreement or loan agreements, which may result in acceleration of the debt, cross-defaults on other debt or a reduction in available liquidity, any of which could harm our results of operations and financial condition.

Operating activities. Net cash provided by operating activities increased by $48.8 million to $99.7 million for the three months ended March 31, 2018 from $50.8 million for the three months ended March 31, 2017 . As the business and net income have grown, cash provided by net income after adding back non-cash charges has increased. For the three months ended March 31, 2018 , this increase was partially offset by an increase in working capital to support the growth of the business. Our largest working capital items are inventory and accounts receivable. Items such as accounts payable to third parties, prepaid expenses and other current assets and accrued expenses and other liabilities are not as significant as our working capital investment in accounts receivable and inventory because of the amount of value added within IPG due to our vertically integrated structure. Accruals and payables for personnel costs including bonuses and income and other taxes payable are largely dependent on the timing of payments for those items. The increased cash flow from operating activities for the three months ended March 31, 2018 primarily resulted from:


•	An increase of $34.4 million in cash provided by net income after adding back non-cash charges to $146.7 million for the three months ended March 31, 2018 as compared to $112.3 million for the same period in 2017 ;


•	An increase of cash provided by accounts receivable of $7.9 million for the three months ended March 31, 2018 as compared to cash used of $22.8 million for the same period in 2017 ; and


•	An increase in cash provided by income taxes. Cash provided by income and other taxes payable was $5.3 million for the three months ended March 31, 2018 as compared to cash used for income and other taxes payable of $10.1 million for the same period in 2017 ; partially offset by


•	An increase in the cash used for inventory. Cash used for inventory was $49.7 million for the three months ended March 31, 2018 as compared to $22.4 million for the same period in 2017 .

Given our vertical integration, rigorous and time-consuming testing procedures for both internally manufactured and externally purchased components and the lead time required to manufacture components used in our finished products, the rate at which we turn inventory has historically been comparatively low when compared to our cost of sales. Also, our historic growth rates required investment in inventories to support future sales and enable us to quote short delivery times to our customers, providing what we believe is a competitive advantage. Furthermore, if there was a disruption to the manufacturing capacity of any of our key technologies, our inventories of components should enable us to continue to build finished products for a period of time. We believe that we will continue to maintain a relatively high level of inventory compared to our cost of sales. As a result, we expect to have a significant amount of working capital invested in inventory. A reduction in our level of net sales or the rate of growth of our net sales from their current levels would mean that the rate at which we are able to convert our inventory into cash would decrease.

Investing activities. Net cash used in investing activities was $39.4 million for the three months ended March 31, 2018 as compared to cash provided by investing activities of $20.4 million in 2017 . The cash used in investing activities in 2018 related

Table of Contents

to $39.1 million of capital expenditures and $0.6 million of net purchases of short-term investments partially offset by $0.2 million of proceeds from sales of property, plant and equipment. The cash provided by investing activities in 2017 related to $42.2 million of net sales proceeds of short-term investments, partially offset by $21.9 million of capital expenditures.

We expect to incur between $170 million and $190 million in capital expenditures. Capital expenditures include investments in facilities and equipment to add capacity worldwide to support anticipated revenue growth. In 2018, we expect capital expenditures to increase as a percentage of revenue to support the growth of our business. The timing and extent of any capital expenditures in and between periods can have a significant effect on our cash flow. If we obtain financing for certain projects, our cash expenditures would be reduced in the year of expenditure. Many of the capital expenditure projects that we undertake have long lead times and are difficult to cancel or defer to a later period.

Financing activities. Net cash used in financing activities was $17.9 million for the three months ended March 31, 2018 as compared to net cash used in financing activities of $3.7 million in 2017 . The cash used in financing activities in 2018 was primarily related the purchase of treasury stock of $20.1 million and payments on our long-term borrowings of $0.9 million . These cash uses were partially offset by proceeds of $3.1 million from the exercise of stock options net of amounts disbursed in relation to shares withheld to cover employee income taxes due upon the vesting and release of restricted stock units. The cash used in financing activities in 2017 was primarily related to the purchase of treasury stock of $12.5 million and payments on our long-term borrowings of $0.8 million . These cash uses were partially offset by proceeds of $9.6 million from the exercise of stock options net of amounts disbursed in relation to shares withheld to cover employee income taxes due upon the vesting and release of restricted stock units.

Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements contained in this Quarterly Report on Form 10-Q except for historical information are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance, trends in our businesses, or other characterizations of future events or circumstances are forward-looking statements.

The forward-looking statements included herein are based on current expectations of our management based on available information and involve a number of risks and uncertainties, all of which are difficult or impossible to accurately predict and many of which are beyond our control. As such, our actual results may differ significantly from those expressed in any forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in Item 1, "Business" and Item 1A, "Risk Factors" of Part I of our Annual Report on Form 10-K for the year ended December 31, 2017 . Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by us or any other person that such results will be achieved, and readers are cautioned not to rely on such forward-looking information. We undertake no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Recent Accounting Pronouncements

See Note 2 in the Notes to Consolidated Financial Statements for a full description of recent accounting pronouncements,

including the respective dates of adoption or expected adoption and effects on our consolidated financial statements contained

in Item 1 of this Quarterly Report.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk in the ordinary course of business, which consists primarily of interest rate risk associated with our cash and cash equivalents and our debt and foreign exchange rate risk.

Interest rate risk . Our investments have limited exposure to market risk. We maintain a portfolio of cash, cash equivalents and short-term investments, consisting primarily of bank deposits, money market funds, certificates of deposit, corporate notes and government and agency securities. None of these investments have a maturity date in excess of one year. Certain interest rates are variable and fluctuate with current market conditions. Because of the short-term nature of these instruments, a sudden

Table of Contents

change in market interest rates would not be expected to have a material impact on our financial condition or results of operations.

We are also exposed to market risk as a result of increases or decreases in the amount of interest expense we must pay on our bank debt and borrowings on our bank credit facilities. Our interest obligations on our long-term debt are fixed either by the underlying agreement or by means of an interest rate swap agreement. Although our U.S. revolving line of credit and our Euro credit facility have variable rates, we do not believe that a 10% change in market interest rates would have a material impact on our financial position or results of operations.

Exchange rates. Due to our international operations, a significant portion of our net sales, cost of sales and operating expenses are denominated in currencies other than the U.S. Dollar, principally the Euro, the Russian Ruble, the Chinese Yuan and the Japanese Yen. As a result, our international operations give rise to transactional market risk associated with exchange rate movements of the U.S. Dollar, the Euro, the Russian Ruble, the Chinese Yuan and the Japanese Yen. The gain on foreign exchange transactions totaled $5.3 million for the three months ended March 31, 2018 compared to the loss of $4.5 million for the three months ended March 31, 2017 . Management attempts to minimize these exposures by partially or fully off-setting foreign currency denominated assets and liabilities at our subsidiaries that operate in different functional currencies. The effectiveness of this strategy can be limited by the volume of underlying transactions at various subsidiaries and by our ability to accelerate or delay inter-company cash settlements. As a result, we are unable to create a perfect offset of the foreign currency denominated assets and liabilities. At March 31, 2018 , our material foreign currency exposure is net U.S. Dollar denominated assets at subsidiaries where the Euro or the Russian Ruble is the functional currency and U.S. Dollar denominated liabilities where the Chinese Yuan is the functional currency. The U.S. Dollar denominated assets are comprised of cash, third party receivables and inter-company receivables. The U.S. Dollar denominated liabilities are comprised of inter-company payables. A 5% change in the relative exchange rate of the U.S. Dollar to the Euro as of March 31, 2018 applied to the net U.S. Dollar asset balances, would result in a foreign exchange gain of $2.5 million if the U.S. Dollar appreciated and a $2.5 million foreign exchange loss if the U.S. Dollar depreciated.

In addition we are exposed to foreign currency translation risk for those subsidiaries whose functional currency is not the U.S. Dollar as changes in the value of their functional currency relative to the U.S. Dollar can adversely affect the translated amounts of our revenue, expenses, net income, assets and liabilities. This can, in turn, affect the reported value and relative growth of sales and net income from one period to the next. In addition changes in the translated value of assets and liabilities due to changes in functional currency exchange rates relative to the U.S. Dollar result in foreign currency translation adjustments that are a component of other comprehensive income or loss.

Foreign currency derivative instruments can also be used to hedge exposures and reduce the risks of certain foreign currency transactions; however, these instruments provide only limited protection and can carry significant cost. We have no foreign currency derivative instrument hedges as of March 31, 2018 . We will continue to analyze our exposure to currency exchange rate fluctuations and may engage in financial hedging techniques in the future to attempt to minimize the effect of these potential fluctuations. Exchange rate fluctuations may adversely affect our financial results in the future.

Table of Contents

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision of our chief executive officer and our chief financial officer, our management has evaluated the effectiveness of the design and operation of our "disclosure controls and procedures" (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this Quarterly Report on Form 10-Q (the "Evaluation Date"). Based upon that evaluation, our chief executive officer and our chief financial officer have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective.

Changes in Internal Controls

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act) that occurred during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we are party to various legal proceedings and other disputes incidental to our business. There have been no material developments to those proceedings reported in our Annual Report on Form 10-K for the year ended December 31, 2017 .

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2017 , which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities



Date	Total Number of Shares (or Units) Purchased		Average Price Paid per Share (or Unit)		Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs	Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs
January 1, 2018 — January 31, 2018	7,515	(2)	$	233.00	—	$	49,316
February 1, 2018 — February 28, 2018	27,869	(1),(2)	241.72		—	42,838
March 1, 2018 — March 31, 2018	72,164	(1),(2)	243.81		—	30,996
Total	107,548		$	242.51	—	$	30,996

(1)

In 2012, our Board of Directors approved "withhold to cover" as a tax payment method for vesting of restricted stock awards for certain employees. Pursuant to the "withhold to cover" method, we withheld from such employees the shares noted in the table above to cover tax withholding related to the vesting of their awards. For the three months ended March 31, 2018 a total of 24,650 shares were withheld at an average price of $243.86

(2)

In July 2016, the Board of Directors authorized a share repurchase program (the "Program"). Under the Program, the Company's management is authorized to repurchase shares of common stock in an amount not to exceed the number of shares issued to employees and directors under its various employee and director equity compensation and employee stock purchase plans from January 1, 2016 through December 31, 2017. The Program limits aggregate share repurchases to no more than $100 million over a period ending June 30, 2018. For the three months ended March 31, 2018 , the Company repurchased 82,898 shares of its common stock with an average price of $242.11 per share in the open market.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Table of Contents

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

(a) Exhibits



Exhibit No.		Description
31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a)
31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a)
32		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 1350
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema
101.CAL		XBRL Taxonomy Extension Calculation Linkbase
101.LAB		XBRL Taxonomy Extension Label Linkbase
101.PRE		XBRL Taxonomy Extension Presentation Linkbase
101.DEF		XBRL Taxonomy Extension Definition Linkbase

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.



	IPG PHOTONICS CORPORATION

Date: May 4, 2018	By:	/s/ Valentin P. Gapontsev
		Valentin P. Gapontsev
		Chairman and Chief Executive Officer (Principal Executive Officer)

Date: May 4, 2018	By:	/s/ Timothy P.V. Mammen
		Timothy P.V. Mammen Senior Vice President and Chief Financial Officer (Principal Financial Officer)

TABLE OF CONTENTS

Part I-financial Informationprint Item 1. Unaudited Interim Financial Statementsprint Item 2. Management's Discussion and Analysis Of Financial Condition and Results Of Operationsprint Item 3. Quantitative and Qualitative Disclosures About Market Riskprint Item 4. Controls and Proceduresprint Part II Other Informationprint Item 1. Legal Proceedingsprint Item 1A. Risk Factorsprint Item 2. Unregistered Sales Of Equity Securities and Use Of Proceedsprint Item 3. Defaults Upon Senior Securitiesprint Item 4. Mine Safety Disclosuresprint Item 5. Other Informationprint Item 6. Exhibitsprint

Exhibits

31.1 Certification of Chief Executive Officer pursuant to Rule13a-14(a) 31.2 Certification of Chief Financial Officer pursuant to Rule13a-14(a) 32 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section1350

Customer name	Ticker
Medtronic plc	MDT
Thermo Fisher Scientific Inc.	TMO

IPGP 10-Q Quarter ended March 31, 2018

Exhibits